C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 451/06 (2006.01) A61K 31/44 (2006.01) A61K 31/443 (2006.01) A61K 31/4436 (2006.01) A61K 31/46 (2006.01) A61K 31/495 (2006.01) A61P 3/04 (2006.01) A61P 25/18 (2006.01) A61P 25/24 (2006.01) C07D 211/46 (2006.01) C07D 295/12 (2006.01) C07D 405/04 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01)
Patent
CA 2610671
Compounds of formula (I) wherein R1 , D, R2 , A and R3 are as described in the specification, pharmaceutically- acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
L'invention concerne des composés de formule (I), dans laquelle R1, D, R2, A et R3 sont tels que définis dans la description. L'invention concerne également des sels pharmaceutiquement acceptables, des procédés de fabrication de ces composés, des compositions pharmaceutiques les contenant, ainsi que des méthodes d'utilisation associées.
Blackwell William C.
Brown Dean
Mclaren Frances M.
Schnecke Volker
Smith Reed W.
Astrazeneca Ab
Mccarthy Tetrault Llp
LandOfFree
Novel mchr1 antagonists and their use for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel mchr1 antagonists and their use for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel mchr1 antagonists and their use for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1961074